Site-directed mutagenesis of the human A1 adenosine receptor: Influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1635-1642

  Barbhaiya, Hemang ^a,b   McClain, Rebecca ^a,b   Ijzerman, Adriaan ^c   Rivkees, Scott A ^a,b,d  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LEIDEN UNIVERSITY   (Netherlands)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 CHLOROADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; AMINO ACID; AMINOPHYLLINE; ASPARTIC ACID; CAFFEINE; GLUTAMIC ACID; LIGAND; SERINE; SODIUM; THREONINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CERCOPITHECIDAE; CHO CELL; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; CELL LINE; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, PURINERGIC P1;

EID: 0030460366     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bruns, R. F. Adenosine receptors: roles and pharmacology. Ann. N. Y. Acad. Sci. 603:211-25 (1990).
2. Olah, M. E., and G. L. Stiles. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:581-606 (1995).
3. Tucker, A. L., and J. Linden. Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27:62-67 (1993).
4. During, M. J., and D. D. Spencer. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neural. 32:618-624 (1992).
5. Rudolphi, K. A., P. Schubert, F. E. Parkinson, and B. B. Fredholm. Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4:346-369 (1992).
6. Pelleg, A., and L. Belardinelli. Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc. Res. 27:54-61 (1993).
7. Olah, M. E., H. Ren, J. Ostrowski, K. A. Jacobson, and G. L. Stiles. Cloning, expression, and characterization of the unique bovine A1 adenosine receptor: studies on the ligand binding site by site-directed mutagenesis. J. Biol. Chem. 267:10764-10770 (1992).
8. Tucker, A. L., A. S. Robeva, H. E. Taylor, D. Holeton, M. Bockner, K. R. Lynch, and J. Linden. Al adenosine receptors: two amino acids are responsible for species differences in ligand recognition. J. Biol. Chem. 269: 27900-27906 (1994).
9. Townsend-Nicholson, A., and P. R. Schofield. A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. J. Biol. Chem. 269:2373-2376 (1994).
10. Rivkees, S. A., M. E. Lasbury, and H. Barbhaiya. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype selective ligands using chimeric A1/A2a adenosine receptors. J. Biol. Chem. 270:20485-20490 (1995).
11. Hibert, M. F., S. Trumpp-Kallmeyer, A. Bruinvels, and J. Hoflack. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 40:8-15 (1991).
12. Huggins, J. P., S. Trumpp-Kallmeyer, M. F. Hibert, and J. M. Hoflack. Modelling and modification of the binding site of receptors. Eur. J. Pharmacol. 245:203-214 (1993).
13. Rivkees, S. A., M. E. Lasbury, G. S. Stiles, O. Henergariu, and G. Vance. The human A1 adenosine receptor: ligand binding properties, sites of somatic expression, and chromosomal localization. Endocrinology 3:623-629 (1995).
14. Ho, S., N. Hunt. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59 (1989).
15. Cullen, B. R. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152:684-704 (1987).
16. Reppert, S. M., D. R. Weaver, J. H. Stehle, and S. A. Rivkees. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol. Endocrinol. 5:1037-1048 (1991).
17. Rivkees, S. A., S. M. Price, and F. C. Zhou. Immunohistochemical detection of Al adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res. 677:193-203 (1995).
18. Swanson, T. H., J. A. Drazba, and S. A. Rivkees. Adenosine A1 receptors are located predominantly on axons in the rat hippocampal formation. J. Comp. Neural. 363:517-531 (1995).
19. McPherson, G. A. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Met. 14:213-228 (1985).
20. Ceresa, B. P., and L. E. Limbird. Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of α2-adrenergic receptor-G-protein interactions: a negative charge at amino acid residue 79 forecasts α2A-adrenergic receptor sensitivity to allosteric modulation by monovalent cations and fully effective receptor/G-protein coupling. J. Biol. Chem. 269:29557-29564 (1994).
21. Horstman, D. A., S. Brandon, A. L. Wilson, C. A. Guyer, E. J. Cragoe, Jr., and L. E. Limbird. An aspartate conserved among G-protein receptors confers allosteric regulation of α2-adrenergic receptors by sodium. J. Biol. Chem. 265:21590-21595 (1990).
22. Fraser, C. M., C. D. Wang, D. A. Robinson, J. D. Gocayne, and J. C. Venter. Site-directed mutagenesis of ml muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol. 36:840-847 (1989).
23. Chung, F. Z., C. D. Wang, P. C. Potter, J. C. Venter, and C. M. Fraser. Site-directed mutagenesis and continuous expression of human β-adrenergic receptors: identification of a conserved aspartate residue involved in agonist binding and receptor activation. J. Biol. Chem. 263:4052-4055 (1988).
24. Strader, C. D., I. S. Sigal, R. B. Register, M. R. Candelore, E. Rands, and R. A. Dixon. Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc. Natl. Acad. Sci. USA 84:4384-4388 (1987).
25. Jensen, S., R. Plaetke, J. Holik, M. Hoff, and P. O'Connell. Linkage analysis of the D1 dopamine receptor gene and six families. Hum. Heredity 42:269-275 (1992).
26. IJzerman, A. P., P. J. van Galen, and K. A. Jacobson. Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor. Drug Des. Disc. 9:49-67 (1992).
27. IJzerman, A. P., E. M. van der Wenden, P. J. van Galen, and K. A. Jacobson. Molecular modeling of adenosine receptors: the ligand binding site on the rat adenosine A2A receptor. Eur. J. Pharmacol. 268:95-104 (1994).
28. Strader, C. D., M. R. Candelore, W. S. Hill, R. A. Dixon, and I. S. Sigal. A single amino acid substitution in the β-adrenergic receptor promotes partial agonist activity from antagonists. J. Biol. Chem. 264:16470-16477 (1989).
29. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 40:168-179 (1991).
30. Weitz, C. J., and J. Nathans. Histidine residues regulate the transition of photoexcited rhodopsin to its active conformation, metarhodopsin II. Neuron 8:465-472 (1992).
31. Adham, N., J. A. Tamm, J. A. Salon, P. J. Vaysse, R. L., Weinshank, and T. A. Branchek. A single point mutation increases the affinity of serotonin 5-HT1D alpha, S-HT1D beta, 5-HT1E and 5-HT1F receptors for betaadrenergic antagonists. Neuropharmacology 33:387-391 (1994).
32. 2 receptor: identification of amino acids necessary for ligand binding and receptor activation. Mol. Pharmacol. 43:931-940 (1993).
33. van der Wenden, E. M., A. P. IJzerman, and W. Soudijn. A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine Al receptor. J. Med. Chem. 35:629-635 (1992).
34. Cristalli, G., M. Grifantini, S. Vittori, W. Balduini, and F. Cattranbeni. Adenosine and 2-chloroadenosine deaza-analogues as adenosine receptor agonists. Nucleosides Nucleotides 4:625-639 (1985).
35. Strader, C. D., M. R. Candelore, W. S. Hill, R. A. Dixon, and I. S. Sigal. A single amino acid substitution in the β-adrenergic receptor promotes partial agonist activity from antagonists. J. Biol. Chem. 264:16470-16477 (1989).
36. Strader, C. D., I. S. Sigal, and R. A. Dixon. Structural basis of beta-adrenergic receptor function. FASEB J. 3:1825-1832 (1989).
37. Strader, C. D., I. S. Sigal, R. B. Register, M. R. Candelore, E. Rand, and R. A. Dixon. Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc. Natl. Acad. Sci. USA 84:4384-4388 (1987).
38. Kim, J., J. Wess, A M. van Rhee, T. Schoneberg, and K. Jacobson. Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor. J. Biol. Chem. 270:13987-13997 (1995).
39. 3 adenosine receptor. Mol. Pharmacol. 45:1101-1111 (1994).